By LSE RNS
BLOCK LISTING SIX MONTHLY RETURN
Date: 20 June 2017
Name of applicant: |
Premier Veterinary Group plc (formerly Ark Therapeutics Group plc)
|
|||
Name of scheme: |
2014 Ark Therapeutics Group plc Enterprise Management Incentive Share Option Plan
|
|||
Period of return: |
From: |
21/12/2016 |
To: |
20/06/2017 |
Balance of unallotted securities under scheme(s) from previous return: |
579,035 ordinary shares of 10 pence each |
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
90,000 |
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
300,000 |
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
369,035 ordinary shares of 10 pence each |
|||
Name of applicant: |
Premier Veterinary Group plc (formerly Ark Therapeutics Group plc)
|
|||
Name of scheme: |
2014 Ark Therapeutics Group plc Unapproved Share Option Plan
|
|||
Period of return: |
From: |
30/03/2017 |
To: |
20/06/2017 |
Balance of unallotted securities under scheme(s) from previous return: |
Nil ordinary shares of 10 pence each |
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
30,000 |
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
Nil |
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
30,000 ordinary shares of 10 pence each |
|||
Name of contact: |
Will Evans, CFO |
Telephone number of contact: |
0117 370 0300 |
You are here: news > regulatory news